Axis NIFTY Healthcare ETF
Category: ETFs
Launch Date: 17-05-2021
AUM:
₹ 18.8 Cr
Expense Ratio
0.34%
Benchmark
NIFTY Healthcare TRI
ISIN
INF846K01Z12
Minimum Investment
5000.0
Minimum Topup
0.0
Minimum SIP Amount
1000
Fund Manager
Shreyash Devalkar, Karthik Kumar
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Axis NIFTY Healthcare ETF | 17.6 | 19.05 | - |
| NIFTY Healthcare TRI | 18.03 | 19.44 | 21.13 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
142.5004
Last change
0.62 (0.4366%)
Fund Size (AUM)
₹ 18.8 Cr
Performance
14.37% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors.
Fund Manager
Shreyash Devalkar, Karthik Kumar
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 20.66 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 9.01 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 8.96 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.1 |
| Dr. Reddys Laboratories Ltd | 7.71 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.39 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.41 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.91 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.73 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.59 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.91 |
| N/A | 0.09 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Axis NIFTY Healthcare ETF | 0.0 |
| Mirae Asset Hang Seng TECH ETF | 0.0 |
| Nippon India ETF Hang Seng BeES | 2.88 |
| Tata Gold ETF | 0.0 |
| LIC MF Gold Exchange Traded Fund | 14.51 |
| Invesco India Gold ETF | 14.32 |
| Axis Gold ETF | 14.11 |
| ICICI Pru Gold ETF | 14.03 |
| ABSL Gold ETF | 13.99 |
| Zerodha Gold ETF | 0.0 |